Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation.
about
Usefulness of a biomarker to identify placental dysfunction in the context of malariaCompeting risks model in screening for preeclampsia in twin pregnancies by maternal factors and biomarkers at 11-13 weeks' gestation.Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre-eclampsia.Prediction of stillbirth from placental growth factor at 19-24 weeks.Prediction of stillbirth from maternal factors, fetal biometry and uterine artery Doppler at 19-24 weeks.Integrated Proteomic and Metabolomic prediction of Term Preeclampsia.Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.Evaluation of sFlt-1/PlGF Ratio for Predicting and Improving Clinical Management of Pre-eclampsia: Experience in a Specialized Perinatal Care Center.Uterine artery pulsatility index at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia.Maternal serum alpha-fetoprotein at 12, 22 and 32 weeks' gestation in screening for pre-eclampsia.Maternal serum soluble fms-like tyrosine kinase-1 at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia.Maternal serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia.Mean arterial pressure at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia.Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 35-37 weeks' gestation.Development of pre-eclampsia within 4 weeks of sFlt-1/PlGF ratio > 38: comparison of performance at 31-34 vs 35-37 weeks' gestation.Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30-37 weeks' gestation.Maternal cardiovascular function at 35-37 weeks' gestation: relation to maternal characteristics.
P2860
Q37554737-F946EA6A-93F7-49A1-BE84-2EC580D87200Q38757227-D4BCF970-FB33-4CE3-9CC5-49B0C4811ABAQ39025500-6A482A45-09D4-4D1F-BFAA-DBE24C486C89Q40472317-374E7712-9BCB-42C9-8841-05A5697D8EB9Q40472344-7B28D9CC-5063-4583-B787-48910A2E40B0Q47143920-25AB81E9-82AB-435F-8D06-B70F883F366EQ48017621-BA25E09A-B411-444D-9E00-2211381C9EEAQ50040133-5113FFC5-0AD2-4409-9C11-642307771530Q50770314-CB084548-5D37-4936-B6E8-B1557F18D75DQ50770330-5E8AE50E-C61F-4B8A-B6CA-3055EC311913Q50770360-F3ACEEAF-1E75-42F0-B9BB-DCD025A5C20EQ50770376-DA51CFE7-A8FD-43FC-A164-84A0054D2103Q50770396-3DA993D9-198B-459A-B96A-34734F22DE38Q50925614-6D3BA36B-E2D2-4DB8-8A34-821FCD6E0D79Q51458630-308C6D35-4490-4A47-90C2-94FD06A5F580Q51516924-F858825C-5E17-4A7D-B0C8-1234A6AA3483Q51793275-97FE19BC-0D1E-4E46-9237-32650C345316
P2860
Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Competing-risks model in scree ...... ers at 35-37 weeks' gestation.
@en
type
label
Competing-risks model in scree ...... ers at 35-37 weeks' gestation.
@en
prefLabel
Competing-risks model in scree ...... ers at 35-37 weeks' gestation.
@en
P2093
P2860
P356
P1476
Competing-risks model in scree ...... ers at 35-37 weeks' gestation.
@en
P2093
P2860
P356
10.1002/UOG.15812
P577
2015-11-13T00:00:00Z